Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:1051-1053
Published online before print March 20, 2003, doi: 10.1161/01.STR.0000061885.90999.A9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/4/1051    most recent
01.STR.0000061885.90999.A9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dietrich, W. D.
Right arrow Articles by Kuluz, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dietrich, W. D.
Right arrow Articles by Kuluz, J. W.

(Stroke. 2003;34:1051.)
© 2003 American Heart Association, Inc.


Emerging Therapies

New Research in the Field of Stroke: Therapeutic Hypothermia after Cardiac Arrest

W. Dalton Dietrich, PhD John W. Kuluz, MD

From the Departments of Neurological Surgery (W.D.D.), Neurology (W.D.D.), and Pediatrics (J.W.K.), University of Miami School of Medicine, Miami, Fla.

Correspondence to W. Dalton Dietrich III, PhD, Scientific Director, The Miami Project to Cure Paralysis, University of Miami School of Medicine, Lois Pope LIFE Center, 1095 NW 14th Terr (R-48), Miami, FL 33136-1060. E-mail ddietrich@miami.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Therapeutic hypothermia as a potential treatment for stroke, cerebral ischemia, and other neurological diseases has gained momentum since the initial discovery that relatively small differences in intraischemic brain temperature critically determine ischemic neuronal vulnerability.1 Since that time, laboratories throughout the world have investigated the potential use of mild-to-moderate hypothermia in many ischemia models.2,3 Various studies have also investigated potential mechanisms contributing to hypothermic protection. Pathomechanisms sensitive to intra- and postischemic temperature reductions and elevations include glutamate release, stabilization of the blood-brain barrier, oxygen radical production, intracellular signal conduction, protein synthesis, ischemic depolarization, reduced cerebral metabolism, membrane stabilization, inflammation, activation of protein kinases, cytoskeletal breakdown, and early gene expression.2,4 Because the pathophysiology of ischemic brain injury is complex, the fact that many injury mechanisms have been reported to be temperature sensitive may account for the dramatic effects of temperature on ischemic outcome. Thus, therapeutic hypothermia has the necessary support from preclinical data to initiate well-designed clinical studies targeting various patient populations.

In a recent issue of The New England Journal of Medicine, the results of 2 randomized clinical trials showed clearly that mild hypothermia improves neurologic outcome and reduces overall mortality in survivors of out-of-hospital–witnessed cardiac arrest.5,6 In the study from Australia, a total of 77 patients who remained comatose after the return of spontaneous circulation (ROSC) were randomized to receive 12 hours of hypothermia or standard normothermic temperature management.5 In that study, surface cooling was begun in the field and the target temperature of 32°C to 34°C was reached . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
ChestHome page
J. Varon and P. Acosta
Therapeutic Hypothermia: Past, Present, and Future
Chest, May 1, 2008; 133(5): 1267 - 1274.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. R. Leon, M. D. Blaha, and D. A. DuBose
Time course of cytokine, corticosterone, and tissue injury responses in mice during heat strain recovery
J Appl Physiol, April 1, 2006; 100(4): 1400 - 1409.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. B. Tatro
Melanocortins Defend their Territory: Multifaceted Neuroprotection in Cerebral Ischemia.
Endocrinology, March 1, 2006; 147(3): 1122 - 1125.
[Full Text] [PDF]


Home page
J. Am. Podiatr. Med. Assoc.Home page
D. G. Armstrong, M. B. Sangalang, D. Jolley, F. Maben, H. R. Kimbriel, B. P. Nixon, and I. K. Cohen
Cooling the Foot to Prevent Diabetic Foot Wounds: A Proof-of-Concept Trial
J Am Podiatr Med Assoc, March 1, 2005; 95(2): 103 - 107.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. R. Fulgham, T. J. Ingall, L. G. Stead, H. J. Cloft, E. F. M. Wijdicks, and K. D. Flemming
Management of Acute Ischemic Stroke
Mayo Clin. Proc., November 1, 2004; 79(11): 1459 - 1469.
[Abstract] [PDF]


Home page
StrokeHome page
Y. Liu, J. D. Barks, G. Xu, and F. S. Silverstein
Topiramate Extends the Therapeutic Window for Hypothermia-Mediated Neuroprotection After Stroke in Neonatal Rats
Stroke, June 1, 2004; 35(6): 1460 - 1465.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Holzer, F. Sterz, W. Behringer, W. D. Dietrich, and J. W. Kuluz
Re: New Research in the Field of Stroke: Therapeutic Hypothermia After Cardiac Arrest * Response
Stroke, August 1, 2003; 34 (8): e103 - e103.
[Full Text] [PDF]